Mineralys Therapeutics

Hiring for 66 positions

Mineralys Therapeutics develops targeted medicines addressing hypertension and related conditions such as chronic kidney disease and obstructive sleep apnea, driven by dysregulated aldosterone. Their lead product, lorundrostat, is a selective aldosterone synthase inhibitor that aims to provide an innovative oral solution for these health issues.
    Workplace
    Job type
    Salary
    Anytime
    Experience